HomeAnswersNeurologyneurofibromatosis

How to slow down the growth of brain tumors in NF1?

This Premium Q&A, reviewed and published, features a real conversation between an iCliniq user and a physician.

Patient's Query

Hello doctor,

I have had NF1 (neurofibromatosis type 1) since childhood, but recently I have started experiencing headaches and some memory problems. An MRI showed a few small tumors near my brain. Can NF1 cause brain tumors, too, or is that rare? I also have painful skin lumps that are increasing with age. Is there any medication that can slow their growth or prevent new ones? I heard MEK inhibitors are used; are they safe for long-term use?

Please advise.

Answered by Dr. Sally Attalah

Education:

BDS

Professional Bio:

Dr. Sally Attalah is an experienced Dental Surgeon with a Bachelor of Dental Surgery earned in 2007, followed by her internship in 2008. She has been an affiliate member of the American Dental Association since 2015, reflecting her commitment to maintaining global standards in dental care. Dr. Sally is dedicated to providing high-quality oral healthcare with a patient-focused approach.

This doctor is not available for online consultations on the platform anymore.

Hello,

Welcome to icliniq.com.

I understand your concern.

Neurofibromatosis type 1 (NF1) is a genetic condition that causes tumors, usually non-cancerous, to grow along the nerves, including those in the brain and spinal cord. NF1 is considered rare, affecting approximately one in 2,500 individuals.

Treatment for NF1:

  1. Vitamin D and calcium supplementation are often recommended to help reduce the risk of osteoporosis, which can be more common in individuals with NF1.
  2. Bisphosphonate therapy may be beneficial in managing bone-related complications associated with NF1.
  3. Targeted therapy like MEK (mitogen-activated protein kinase kinase) inhibitors such as Selumetinib and Mirdametinib has shown effectiveness in reducing the size and symptoms of inoperable plexiform neurofibromas in many individuals with NF1.

The United States Food and Drug Administration (FDA) has approved Koselugo (Selumetinib) for the treatment of children with inoperable plexiform neurofibromas, which are a common manifestation of NF1.

I hope this information helps answer your questions.

Thank you.

Medically reviewed by iCliniq medical review team
Published At July 16, 2025
Reviewed At March 5, 2026

Education:

BDS

Professional Bio:

Dr. Sally Attalah is an experienced Dental Surgeon with a Bachelor of Dental Surgery earned in 2007, followed by her internship in 2008. She has been an affiliate member of the American Dental Association since 2015, reflecting her commitment to maintaining global standards in dental care. Dr. Sally is dedicated to providing high-quality oral healthcare with a patient-focused approach.

This doctor is not available for online consultations on the platform anymore.

Same symptoms don't mean you have the same problem. Consult a doctor now!

Education:

BDS

Professional Bio:

Dr. Sally Attalah is an experienced Dental Surgeon with a Bachelor of Dental Surgery earned in 2007, followed by her internship in 2008. She has been an affiliate member of the American Dental Association since 2015, reflecting her commitment to maintaining global standards in dental care. Dr. Sally is dedicated to providing high-quality oral healthcare with a patient-focused approach.

This doctor is not available for online consultations on the platform anymore.

Listen to related tracks in our music library
Comprehensive Second Opinion

Ask your health query to a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.